Last $29.03 USD
Change Today +0.11 / 0.38%
Volume 185.6K
IPXL On Other Exchanges
Symbol
Exchange
Frankfurt
As of 3:54 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bryan M. Reasons

Chief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance, Impax Laboratories Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

47$1,451,471
As of Fiscal Year 2013

Background*

Mr. Bryan M. Reasons has been Chief Financial Officer and Senior Vice President at Impax Laboratories Inc. since December 13, 2012 and also serves as its Principal Accounting Officer. Mr. Reasons served as an Acting Chief Financial Officer of Impax Laboratories Inc. since June 29, 2012 and served as its Vice President of Finance until December 2012.

Corporate Headquarters*

30831 Huntwood Avenue
Hayward, California 94544

United States

Phone: 510-476-2000
Fax: 510-471-3200

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$385,000
Total Annual Compensation$385,000

Stock Options*

Restricted Stock Awards$266,252
All Other Compensation$65,109
Unexercisable Options52,000
Unexercisable Options Value$371,800
Total Value of Options$371,800
Total Number of Options52,000

Total Compensation*

Total Annual Cash Compensation$793,144
Total Short Term Compensation$385,000
Other Long Term Compensation$331,361
Total Calculated Compensation$1,451,471
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPXL:US $29.03 USD +0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Arthur P. Bedrosian J.D.Chief Executive Officer, President, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$437.5K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.